https://adisinsight.springer.com/drugsafety/800915669?error=cookies_not_supported&code=9a697051-6eac-4369-9496-ecb8f127d0bb
Abacavir - AdisInsight
A 36-year-old man developed disseminated intravascular coagulation as a manifestation of a hypersensitivity reaction while receiving abacavir for the treatment
abacaviradisinsight
https://myhealth.alberta.ca/Health/medications/Pages/conditions.aspx?hwid=fdb1636
Abacavir/Dolutegravir/Lamivudine - Oral
abacavirdolutegravirlamivudineoral
https://blogs.nejm.org/hiv-id-observations/index.php/tag/abacavir/
Abacavir Archives - HIV and ID Observations HIV and ID Observations
abacavirarchivesidobservations
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e5cbf204-c10d-444b-aba0-180a30645d55
DailyMed - ABACAVIR solution
dailymedabacavirsolution
https://adisinsight.springer.com/drugsafety/803540234?error=cookies_not_supported&code=3b656774-b74b-4ffe-9491-f58eb3f2913a
Abacavir/dolutegravir/lamivudine/calcium-carbonate/vitamins interaction - AdisInsight
A 35-year-old woman showed viral load increased following concomitant administration of abacavir/dolutegravir/lamivudine, unspecified vitamins and calcium
calcium carbonateabacavirdolutegravirlamivudinevitamins
https://adisinsight.springer.com/drugsafety/809092486?error=cookies_not_supported&code=e5861689-5775-4570-9a9d-0c2e1da41eaa
Qiagen launches new test for adverse reactions to abacavir - AdisInsight
The test, developed by Olerup SSP AB, detects genetic variations in the Human Leucocyte Antigen (HLA) system that can indicate a risk for severe adverse
new testadverse reactionsqiagenlaunchesabacavir
https://adisinsight.springer.com/drugsafety/803407753?error=cookies_not_supported&code=4501ee82-80e0-4aa1-9531-b8dd0575b27a
Lamivudine/zidovudine/abacavir - AdisInsight
A 72-year-old man developed diabetes mellitus and hypertension during treatment with lamivudine, zidovudine and abacavir for HIV infection [dosages, routes and
lamivudinezidovudineabacaviradisinsight
https://adisinsight.springer.com/drugsafety/800724960?error=cookies_not_supported&code=6a80258e-cea0-4894-ad9c-61d7f303cbdf
Safety card and boxed warning for abacavir - AdisInsight
Warnings about hypersensitivity reactions to Glaxo Wellcome's nucleoside analogue abacavir [`Ziagen'] will be included in a wallet safety card and in a boxed
safety cardboxedwarningabacaviradisinsight
https://boris-portal.unibe.ch/entities/publication/6d447af3-defc-4d06-8743-3d9ed3cda561
A Randomized Trial of Simplified Maintenance Therapy with Abacavir, Lamivudine, and Zidovudine in...
This randomized study evaluated the efficacy and tolerability of continued treatment with protease inhibitor plus nucleoside-analogue combination regimens (n =...
https://journals.plos.org/plosclinicaltrials/article/comments?id=10.1371/journal.pctr.0020013
Factors in AIDS Dementia Complex Trial Design: Results and Lessons from the Abacavir Trial | PLOS...
ObjectivesTo determine the efficacy of adding abacavir (Ziagen, ABC) to optimal stable background antiretroviral therapy (SBG) to AIDS dementia complex (ADC)...
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3ddcbccc-b538-4223-9a33-8673c6afcb76
These highlights do not include all the information needed to use ABACAVIR AND LAMIVUDINE TABLETS...
https://www.cochrane.org/evidence/CD008270_abacavir-based-triple-nucleoside-regimens-maintenance-therapy-patients-hiv
Abacavir-based triple nucleoside regimens for maintenance therapy in patients with HIV | Cochrane
https://pubmed.ncbi.nlm.nih.gov/30999834/
Efficacy and safety of abacavir/lamivudine with raltegravir in treatment-experienced and...
Raltegravir (RAL) is an HIV-1 integrase strand transfer inhibitor that is well established as a component of highly active antiretroviral therapy regimens for...
efficacy and safetyin treatmentabacavir